Jacques De Grève - Concepedia

Author

Jacques De Grève

Also Known As

Barbara Burwinkel, De Greve J, De Greve, Jacques, De Grève, Jacques, E Salamon, Greve, J., J De Greve, J De Grève, J DeGREVE, J DeGreve

471

Publications

12.4K

Citations

H-Index

208

Concepts

All Affiliations

Vrije Universiteit Brussel Universitair Ziekenhuis Brussel KU Leuven Institut Jules Bordet Ghent University Hospital

About

Jacques De Grève is an author at Vrije Universiteit Brussel specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	94	5.3K
2	Health Sciences	18	25	1.1K
3	Engineering	7	7	349
4	Natural Sciences	6	6	283
5	Public Health	3	3	75

Jacques De Grève

166

Publications

11.5K

Citations

H-Index

Page 1

	Year	Citations
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma Ghassan K. Abou‐Alfa, Lawrence H. Schwartz, Sergio Ricci, Journal of Clinical Oncology	2006	1.2K
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in <i>BRCA</i> Carrier Ovarian Cancer Correlating With Platinum-Free Interval Peter C.C. Fong, Timothy A. Yap, David S. Boss, Journal of Clinical Oncology	2010	984
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1 Marie Marchand, Nicolas van Baren, P. Weynants, International Journal of Cancer Subcutaneous InjectionsImmunologyImmunoeditingPathologyImmunotherapeutics	1999	786
Phase I Study of <sup>68</sup>Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, Journal of Nuclear Medicine	2015	419
Performance of Two Geriatric Screening Tools in Older Patients With Cancer Cindy Kenis, Lore Decoster, Katrien Van Puyvelde, Journal of Clinical Oncology	2013	381
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials Ignace Vergote, Corneel Coens, Matthew Nankivell, The Lancet Oncology Surgical OncologyGynecological SurgeryIndividual Patient DataMedicineChorus Trials	2018	290
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu Jacques De Grève, Erik Teugels, Caroline Geers, Lung Cancer	2012	277
miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells Gang Chen, Ijeoma Adaku Umelo, Shasha Lv, PLoS ONE ImmunologyCell DeathCancer BiologyTumor BiologyOncology	2013	266
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma Bart Neyns, Jan Sadones, E. Joosens, Annals of Oncology MedicineMetronomic TherapyRecurrent High-grade GliomaNeurologyHigh-grade Gliomas	2009	239
Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study Martin Schüler, Richard Herrmann, Jacques De Grève, Journal of Clinical Oncology	2001	210

Page 1